September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Evaluation of angle closure as a risk factor for reduced corneal endothelial cell density
Author Affiliations & Notes
  • Varshini Varadaraj
    Wilmer Eye Institute, Baltimore, Maryland, United States
  • Sabyasachi S Sengupta
    Aravind Eye Hospital, Pondicherry, India
  • Krishnamurthy Palaniswamy
    Aravind Eye Hospital, Pondicherry, India
  • Kavitha Srinivasan
    Aravind Eye Hospital, Pondicherry, India
  • Mohideen Abdul Kader
    Aravind Eye Hospital, Tirunelveli, India
  • Ganesh Raman
    Aravind Eye Hospital, Coimbatore, India
  • Sharmila Reddy
    Aravind Eye Hospital, Madurai, India
  • Pradeep Y Ramulu
    Wilmer Eye Institute, Baltimore, Maryland, United States
  • Rengaraj Venkatesh
    Aravind Eye Hospital, Pondicherry, India
  • Footnotes
    Commercial Relationships   Varshini Varadaraj, None; Sabyasachi Sengupta, None; Krishnamurthy Palaniswamy, None; Kavitha Srinivasan, None; Mohideen Kader, None; Ganesh Raman, None; Sharmila Reddy, None; Pradeep Ramulu, None; Rengaraj Venkatesh, None
  • Footnotes
    Support  Research to Prevent Blindness and Morton F. Goldberg Director's Discovery Fund
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5137. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Varshini Varadaraj, Sabyasachi S Sengupta, Krishnamurthy Palaniswamy, Kavitha Srinivasan, Mohideen Abdul Kader, Ganesh Raman, Sharmila Reddy, Pradeep Y Ramulu, Rengaraj Venkatesh; Evaluation of angle closure as a risk factor for reduced corneal endothelial cell density. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5137.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Acute angle closure attacks are frequently accompanied by corneal edema. However, little is known about the status of corneal endothelial cells at early stages of angle closure in eyes naïve to prior surgery, iridotomy, or severe IOP elevation. Here, we compare endothelial cell density (ECD) in unoperated eyes with open angles and eyes at various stages of angle closure disease.

Methods : This cross sectional study evaluated both eyes of sibling pairs recruited from one of 4 Aravind Eye Hospitals in Tamil Nadu, India, between September 2012 and May 2014. Masked examiners completed gonioscopic evaluation and eyes were classified as 1) open angle (OA), 2) primary angle closure suspect (PACS), or 3) primary angle closure/primary angle closure glaucoma (PAC/PACG). Specular microscopy was performed in both eyes and group differences in endothelial cell density were analyzed using a nested multilevel model with mixed effects to account for clustering at familial and individual levels.

Results : Analyses included 814 eyes of 407 patients, including 127 eyes (15.6%) with PAC/PACG, 466 (57.3%) with PACS, and 221 (27.1%) with OA. Participants were predominantly female (69.8%) and mean age was 49.2 (SD: 8.6) years. Lower ECD was observed with increasing age (β =-6.3 cells/mm2 [95% CI: -9.3 to -3.3] per year, p<0.001), greater irido-trabecular contact (β =-15.6 cells/mm2 [95% CI: -28.3 to -2.9] per quadrant of contact, p=0.016), and shallow (<2.5mm) anterior chamber (AC) depth (β =-40 cells/mm2 [95%CI: 78.9 to 1.1] vs. deeper [>2.5 mm] AC depth, p=0.044). In age-adjusted analyses, PACS eyes had a lower ECD than OA eyes (β=-54.7 cells/mm2 [95% CI=-47.8 to -85.3], p=0.018) though PAC/PACG eyes were not significantly different than OA eyes (β=-18.6 cells/mm2 [95% CI=-85.9 to 2.5], p=0.058).

Conclusions : Lower ECD may be present in eyes with angle closure, particularly those with a shallower AC and/or greater iridotrabecular contact, even prior to initiation of treatment. Additional longitudinal studies are needed to further establish whether these factors are associated with higher rates of endothelial cell loss.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×